AbbVie
ABBV
$287.81
Share price
-3.74%
Change (1 day)
18.44%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Earnings for AbbVie (ABBV)
Earnings in 2024 (TTM): C$4.87 Billion
According to AbbVie's latest financial reports the company's current earnings are C$56.33 Billion. a decrease over its 2023 earnings that were of C$8.93 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for AbbVie from 2011 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | C$5.31 B | -40.54% |
| 2023 | C$8.93 B | -53.62% |
| 2022 | C$19.26 B | 3.76% |
| 2021 | C$18.56 B | 282.25% |
| 2020 | C$4.85 B | -59.67% |
| 2019 | C$12.04 B | 62.13% |
| 2018 | C$7.42 B | -32.74% |
| 2017 | C$11.04 B | -1.99% |
| 2016 | C$11.27 B | 18.65% |
| 2015 | C$9.49 B | 180.5% |
| 2014 | C$3.38 B | -55.57% |
| 2013 | C$7.62 B | -6.86% |
| 2012 | C$8.18 B | 56.05% |
| 2011 | C$5.24 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | C$15.88 B | 199.06% | 🇺🇸 USA |
 | -C$11.98 Billion | -325.48% | 🇺🇸 USA |
 | C$18.12 B | 241.24% | 🇺🇸 USA |
 | C$6.58 B | 24.03% | 🇺🇸 USA |
 | C$0.98 B | -81.43% | 🇺🇸 USA |
 | C$2.72 B | -48.71% | 🇺🇸 USA |
 | C$6.28 B | 18.26% | 🇬🇧 UK |
 | C$14.91 B | 180.76% | 🇬🇧 UK |
 | C$0.73 B | -86.19% | 🇺🇸 USA |